US FTC suspends challenge to block Amgen ' s $27.8 bln deal for Horizon Therapeutics

An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo Acquire Licensing Rights Aug 26 (Reuters) - The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's (AMGN.O) $27.8 billion purchase of…#amgen #southsanfrancisco #ftc #horizontherapeutics #horizon #tepezza #thousandoaks #medicare

Source: Reuters: Health - August 26, 2023 Category: Consumer Health News Source Type: news